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Donor human milk is pasteurized to prevent the potential risk of the transmission of pathogens
to preterm infants. Currently, Holder pasteurization (human milk held at 62·5 °C for 30min) is used
in most human milk banks, but has the disadvantage that it results in excessive inactivation of
important bioactive components. Power-ultrasound (20–100 kHz) is an emerging technology for the
preservation of foods and could be an alternative method for the treatment of humanmilk. The aim of
this studywas to investigate the effect of different ultrasound settings on the elimination of Escherichia
coli and the retention of bile salt stimulated lipase (BSSL) activity. Ultrasonication with a constant
power decreased Esch. coli viability exponentially over time until the processing temperature
increased to sub-pasteurization level to between 51·4 and 58·5 °C, then a log10 1·3 decrease was
observed (P<0·05). BSSL activity decreased to 91% until a temperature of 51·4 °C and then it
decreased to 8% between 51·4 and 64·9 °C. Ultrasonication with a constant energy and various
power and exposure times showed the highest temperature (53·7 °C) when treated with the longest
exposure time and lowest ultrasound-power (276 s at 3·62W) compared with 37·6 °C for 39 s
at 25·64W. The findings predict that the viability of Esch. coli could be reduced by log10 5 with a
minimal loss of activity of BSSL by applying 13·8 kJ of energy in 12ml of human milk using high
ultrasound power over a short exposure time to ensure that the temperature remains below the critical
level for protein denaturation. Alternatively, the use of lower power settings such as the 26W used in
the present studies would require a cooling system to ensure the human milk BSSL was protected
against temperature denaturation.
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Donor human milk is the best alternative when mothers’
own milk is not available for the preterm infant because
it contains nutritional, bioactive, protective and develop-
mental components that cannot be found in infant formula
(Wight, 2001). However, to prevent the potential risk for
the transmission of pathogens from donor mothers to preterm
infants, the donor milk is pasteurized.
Holder pasteurization is a low-temperature long-time
(LTLT) heat preservation method that is widely used in
milk banks. Human milk is heated in a water bath and held
at 62·5 °C for 30min (Arnold & Tully, 1994; Balmer &
Williams, 1995; Hartmann et al. 2007). This treatment is
capable of a log10 5 reduction of bacteria including
Escherichia coli, Staphylococcus epidermidis, Enterobacter
cloacae, Bacillus cereus and Staphylococcus aureus (Czank
et al. 2009). However, bioactive proteins are only partially
preserved during this process. For example, 72% of sIgA,
22% of lactoferrin and 39% of lysozyme were retained
after Holder pasteurization. Furthermore, the retention of
bile salt stimulated lipase (BSSL) was reported to be less
than 1% (Henderson et al. 1998; Tully et al. 2001; Czank
et al. 2009). BSSL transforms triacylglycerol into mono-
glycerides and free fatty acids which aids in digestion of
fat for the infant (Hernell & Bläckberg, 1994). BSSL is a very
heat labile enzyme and depending on exposure time the
inactivation starts at 45 °C (Wardell et al. 1984). It is likely
that the inactivation of BSSL through the Holder pasteuriza-
tion process is responsible for the lower growth rates of*For correspondence; e-mail: 20795312@student.uwa.edu.au
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preterm infants fed pasteurized donor human milk com-
pared with preterm infants fed mothers’ own milk
(Williamson et al. 1978; Andersson et al. 2007).
Treatments with power-ultrasound (20–100 kHz) are an
emerging technology for the preservation of food alone
(D’Amico et al. 2006; Chouliara et al. 2010; Wang et al.
2010) and in combination with other novel processing
technologies (Walkling-Ribeiro et al. 2009a, b; Arroyo et al.
2011). Power-ultrasound creates cavitation, that is, the
formation, growth and implosive collapse of bubbles in
liquids. During the collapse of these bubbles localised
hot spots occurs with temperatures of roughly 5000 °C,
pressures of about 50MPa and a lifetime of a few
microseconds (Suslick, 1990). The pressure changes result-
ing from these implosions create shock waves that disrupt
the cellular membranes of bacteria resulting in cell lysis
(Allison et al. 1996; Cameron et al. 2008). The combined
effect of ultrasound and heat on human milk has been found
to inactivate Esch. coli and Staph. epidermidis with a greater
retention of sIgA, lysozyme, lactoferrin and BSSL than with
Holder pasteurization (Czank et al. 2010).
The aim of this study was to investigate the effect of
different ultrasound settings on the elimination of Esch. coli
and preservation of BSSL activity in human milk. In a first
experiment different ultrasound-energies were created
by holding ultrasound-power constant and varying the
exposure times. In a second experiment ultrasound-energy
was held constant with varying ultrasound-power and
exposure times.
Methods and Materials
Sample collection
Frozen humanmilk samples were donated by 3mothers with
excess milk supply. The collection of the milk was approved
by the Human Research Ethics Committee of the University
of Western Australia (RA/4/1/2369). All donors gave written
consent for their donations to be used in research and all
samples were de-identified.
Sample preparation
Escherichia coli K12 (ATCC1498, Southern Biological,
Nunawading, Vic, Australia) was cultured in nutrient
broth (Nutrient Broth No. 2, Oxoid Australia Pty Ltd,
Adelaide, SA, Australia) over night at 37 °C and enumerated
using the optical density method with previously con-
structed standard curves (Monod, 1949) measured with
a spectrophotometer at 600 nm (PowerWave, Biotek,
Winooski, VT, USA). The culture was then diluted and
inoculated into previously thawed and pooled (3 donors)
human milk to target a maximum accepted concentration
in milk banks of 105 CFU/ml (colony forming units per
millilitre) (Hartmann et al. 2007) and portioned into 12 ml
samples and brought to 20 °C using a water bath (CC-1,
Huber GmbH, Offenburg, Germany).
Ultrasonication
A 20 kHz ultrasonic processor fitted with a 6mm stepped
microtip (VCX 130, Sonics & Materials Inc., Newtown, CT,
USA) for a batch volume between 10 and 50ml with a
maximum amplitude of 123 μm was used for all exper-
iments. Human milk (12 ml) was treated in batch mode
(10 samples for each treatment condition) using 25ml
polystyrene test tubes (inner-diameter 25 mm) with 12 mm
gap between the bottom of the tube and the microtip
surface (approximately half the height of human milk).
Temperature was recorded using a type T thermocouple
(MT-29/5, Physitemp Instruments Inc., Clifton, NJ, USA) and
USB data-logger (THERMES USB, Physitemp Instruments
Inc., Clifton, NJ, USA) with data acquisition software
(DASYlab10·0, Measurement Computing Corp., Norton,
MA, USA) at a sampling rate of 16 Hz (Fig. 1). After
treatment, the tube with human milk was transferred to
an ice bath. Aliquots where taken and kept frozen at80 °C
until the BSSL assay was performed. Cooled samples were
transferred for immediate microbiological analyses.
Constant ultrasound-power and varying exposure times
The ultrasound processor was set on maximal amplitude
and generated an ultrasound-power of 26W. Human milk
was treated for different times (19·2, 38·4, 57·6, 76·8, 96 and
115·2 s) to achieve an applied ultrasound-energy (500,1000,
1500, 2000, 2500 and 3000 J), respectively.
Constant ultrasound-energy and varying ultrasound-power
and exposure time
The same ultrasound-energy (1000 J) was applied with
different time-power ratios (276 s at 3·62W; 114·5 s at
Stepped microtip 
Type T thermocouple 
Polystyrene test tube 
Human milk
Fig. 1. Ultrasonication set-up.
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8·73W; 70·5 s at 14·18W; 50·5 s at 19·8W and 39 s at
25·64W).
Bacteria analysis
Cooled untreated and ultrasonicated samples (5 μl) were
plated in duplicates onto nutrient agar (Plain agar, Southern
Biological, Nunawading, Vic, Australia/Nutrient Broth
No. 2, Oxoid Australia Pty Ltd, Adelaide, SA, Australia)
and incubated at 37 °C for 18 h. The numbers of colonies
were then enumerated to determine the reduction in
bacterial number following the ultrasound processing
based on CFU/ml. Detection limit was at 200 CFU/ml.
BSSL assay
The BSSL activity in human milk was determined using a
lipase assay kit (QuantiChrom Lipase Assay Kit, BioAssay
Systems, Hayward, CA,USA). The frozen (80 °C) untreated
and ultrasonicated samples were thawed and brought
to 37 °C, diluted (1/100, v/v) with double deionized
water and the assay was performed in duplicate according
to kit instructions. The absorbance was determined with
a spectrophotometer at 412 nm (PowerWave, Biotek,
Winooski, VT, USA) and transformed into BSSL activity per
litre (U/l) based on the formula in the kit instruction. The kit
linear detection range is between 40 and 1600 U/l lipase
activity in the 96-well plate assay. Unit definition: one unit
of enzyme catalyses the cleavage of 1·0 μmole of substrate
per min under the assay conditions (pH 8·5). The coefficient
of variation (CV) within groups was <6% unless otherwise
stated.
Statistical analysis
Results are presented as treatment means±SD values
unless otherwise stated. All analyses were carried out
using R 2.9.2 for Mac OS X (R: A Language and
Environment for Statistical Computing. R Foundation for
Statistical Computing, Vienna, 2009). ANOVA models with
Tukey’s HSD Post Hoc test were used to compare the
values between groups (statistical significant when P<0·05,
confidence level 95%). Graphical modelling was performed
with OpenOffice 3.2.0 Spreadsheet (Sun Microsystems Inc.
based on OpenOffice.org)
Results
Effect of holding ultrasound-power constant and varying the
exposure times
A reduction of Esch. coli viability (CFU/ml) over time was
observed when human milk was treated using ultrasound-
power of 26W. Untreated samples (0·0 s) inoculated with
Esch. coli gave a total count of 221600±48157 CFU/ml
(n=10). The temperature before treatment was 20·0±0·4 °C.
After 76·8, 96·0, and 115·2 s of treatment the Esch. coli
viability was reduced to 42160±13598, 1611±1334 and
undetectable CFU/ml (P<0·05) (n=10) with the temperature
of the human milk increasing up to 51·4±0·3, 58·5±0·5,
and 64·9±1·2 °C, respectively (P<0·05) (n=10). There was
a significant exponential regression (R2 of 0·976) for
bacterial count from untreated samples up to an exposure
time of 76·8 s (Fig. 2).
Untreated human milk had a BSSL activity of
46253±1969 U/l (n=6). The BSSL activity was significantly
reduced to 93% between 0·0 and 19·2 s (P<0·05) but then
remained relatively constant between 19·2 and 76·8 s
(P>0·9) before decreasing significantly from 91 to 76%
(P<0·05) between 76·8 and 96·0 s and to 8% at 115·2 s
(P<0·05). Over this latter period the BSSL activity decreased
from 42052±1365 U/l at 76·8 s and 34962±1268 U/l
at 96·0 s (CV <6%) to only 3858±1921 U/l (CV <50%)
at 115·2 s (n=6) (Fig. 3).
Effect of holding ultrasound-energy constant and varying the
ultrasound-power and exposure time
Untreated humanmilk inoculated with Esch. coli gave a total
bacteria concentration of 204760±38770 CFU/ml (n=10).
Human milk treated with constant ultrasound-energy
(1000 J) but varying ultrasound-power and exposure time
showed a significant reduction of Esch. coli cell concen-
tration compared with untreated human milk (P<0·05).
Furthermore, a significant reduction in the Esch. coli load
was found between the human milk treated with the
longest exposure time and lowest power (276 s at 3·62W;
7700±3731 CFU/ml) and all the other shorter but more
powerful ultrasound settings (P<0·05) (Fig. 4). However,
there was no significant difference in Esch. coli elimination
between the treatments 114·5 s at 8·73W, 70·5 s at 14·18W,
50·5 s at 19·8W and 39 s at 25·64W (P>0·1).
Fig. 2. Effect of holding ultrasound-power constant (26W) and
varying the exposure times on Esch. coli count (o, fine dashed line)
and exponential regression for Esch. coli count between 0·0 and
76·8 s (solid line), and processing temperature (.) and its linear
regression trend (long dashed line). All values are mean±SD (n=10).
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The temperature before ultrasonication was at
20·0±0·2 °C. The temperature after treatment was highest
for the treatment with the longest time and lowest power.
The temperature then progressively and significantly de-
creased at each time by power change as exposure time
decreased from 276 to 39 s (P<0·05). Thus, the highest
temperature of 53·7±0·5 °C was observed at 276 s at
3·62W and the lowest temperature of 37·6±0·3 °C was
observed at 39 s at 25·64W (n=10) (Fig. 4).
Untreated human milk had a BSSL activity of
53408±2590U/l (n=7) and was only significantly reduced
by the longest treatment time at the lowest power (276 s at
3·62W) with the activity decreasing to 48502±2094 U/l
(n=7), that is, to 91% of the untreated human milk BSSL
activity (P<0·05) (Fig. 4).
Discussion
Effect of holding ultrasound-power constant and varying the
exposure times
A previous study reported a synergistic effect when
thermal and ultrasound treatments were used in combi-
nation (Czank et al. 2010). The time to reduce the bacterial
content by log10 5 was significantly reduced when applied
to human milk that had a starting temperature of either
45 or 50 °C. However, ultrasound treatment of 60 ml
human milk resulted in a consistent increase of 10·3 °C
from the starting temperature which stabilised within
three minutes of the application of ultrasound. In our
study the application of ultrasound to 12ml human milk
with a starting temperature of 20 °C resulted in a linear
increase in temperature over a period of 115·2 s (Fig. 2).
We found an exponential decrease in the Esch. coli cell
concentration up to 51·4 °C (76·8 s exposure to ultrasound)
and followed by a rapid decrease (log10 1·3) in viability
between 51·4 and 58·5 °C (96 s). It is of interest that the
Esch. coli cells, when exposed to heat only, decreased when
the temperature was increased to 56 °C (Wills et al. 1982;
Czank et al. 2009). A possible explanation for this trend
could be that the rapid decrease in Esch. coli occurring
as the temperature increased from 51·4 to 58·5 °C was
related to a synergistic effect of ultrasound and temperature
(Fig. 2), because the application of temperature alone
using Holder pasteurization at 57 °C required a holding
time of 16·4 min (Czank et al. 2009) to obtain a similar log10
decrease in Esch. coli to that observed as the temperature
increase from 51·4 to 58·5 °C (Fig. 2).
In contrast to the inactivation of the coliform bacterium,
the loss in activity of BSSL occurred in two stages; from
100 to 93% BSSL activity between 20 and 28 °C and then
from 91 to 8% between 51·4 and 64·9 °C (Fig. 3). Since
it has been reported that BSSL is heat stable up to 45 °C
(Wardell et al. 1984), the initial significant but small
decrease in BSSL activity may have been due to the exposure
to ultrasound. However, the BSSL activity remained constant
from 28 and 51·4 °C, and this suggests that if the temperature
of the human milk is maintained below 51·4 °C the length
of exposure to ultrasound would have a small effect on
BSSL activity (Fig. 3). The high CV of 50% for BSSL activity at
115·2 s can be explained by the proximity to the linear
detection range limit for this enzyme activity assay kit.
The large discrepancy between the exponential loss
of Esch. coli and the relative stability of BSSL activity
between 20 and 51·4 °C suggests that initially ultrasound
exposure caused cell death by disrupting the cell mem-
branes of Esch. coli resulting in cell lysis (Allison et al. 1996;
Cameron et al. 2008). Subsequently, between 51·4 and
58·5 °C therewas a significant decrease in both BSSL activity
and Esch. coli count suggesting that this resulted from
the combined effect of ultrasound and temperature causing
the denaturation of both BSSL and functional proteins
present in Esch. coli.
Fig. 3. Effect of holding ultrasound-power constant (26W) and
varying the exposure times on BSSL activity (o, solid line) and
processing temperature (.) and its linear regression trend (long
dashed line). All values are mean±SD (n=6).
Fig. 4. Effect of holding ultrasound-energy constant (1000 J) and
varying the ultrasound-power and exposure time. Esch. coli count
(grey) (n=10), BSSL activity (white) (n=7) and final-temperature
(black) (n=10). All values are mean±SD.
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Effect of holding ultrasound-energy constant and varying the
ultrasound-power and exposure time
At constant ultrasound-energy (1000 J), the increase in
temperature was highest when the human milk was treated
for the longest time at the lowest ultrasound-power (276 s at
3·62W) and lowest when treated for the shortest time
at the highest power (39 s at 25·64W) (Fig. 4). This finding
demonstrates that the longer exposure time, rather than
high ultrasound power, was responsible for the increase in
temperature. Although, treatment at the longest time at
the lowest power was the most effective in reducing the
viability of Esch. coli, this longer exposure time resulted
in a temperature that was approaching those associated
with protein denaturation and compromised retention
of the BSSL activity (Figs. 3 & 4). Furthermore, the BSSL
activity was reduced at this setting (276 s at 3·62W) but only
to 91% of the untreated activity (Fig. 4). These findings
again focus on a critical temperature being important in
relation to decreasing both Esch. coli cell numbers and
BSSL activity.
Extrapolation of the exponential regression for the
reduction in Esch. coli from 0·0 s to 76·8 s, that is, during
the time that ultrasound alone appeared to reduce
bacteria (Fig. 2), predicts that there would be a log10 5
reduction in Esch. coli viability at 530 s. By 530 s with
ultrasound power set at 26W, it can be calculated that
the human milk would be subjected to 13·8 kJ of energy.
With constant ultrasound-power it was found that the
increase in temperature was linear up to 115·2 s (64·9 °C)
(Fig. 2). Furthermore when the ultrasound-energy was held
constant the heating effect on human milk was the lowest
when it was treated with high ultrasound-power and short
exposure times (Fig. 4). Therefore, these findings predict
that the loss of activity of BSSL could be minimised and
the viability of Esch. coli could be reduced by log10 5 by
applying 13·8 kJ of energy using high ultrasound power
over a short exposure time to ensure that the temperature
remains below the critical level for protein denaturation.
Alternatively, the use of lower power settings such as the
26W used in the present studies would require a cooling
system to ensure the humanmilk BSSL activity was protected
against temperature denaturation.
Although this study has only investigated the effects of
ultrasonication on BSSL and Esch. coli, previous studies
using either the LTLT Holder pasteurization or ultrasound
processing methods have shown that other important
proteins in human milk (sIgA, lactoferrin and lysozyme)
were more resistant than BSSL to both forms of treatment
types (Tully et al. 2001; Czank et al. 2010).
On the other hand, rod-shaped bacteria such as Esch. coli
were reported to have less resistance to ultrasound cavitation
than coccoid bacteria (Zenker et al. 2003). Therefore, it
could be expected that a longer exposure time will be
required for coccoid bacteria, such as Staph. epidermidis
and Staph. aureus, that are also commonly found in human
milk. In this connection, Czank et al. (2010) found that
Esch. coli in human milk required 5·94min exposure to
ultrasound to achieve a log10 1 reduction in bacteria load,
whereas, Staph. epidermidis required 16·01min for a log10
1 reduction under similar conditions (Czank et al. 2010).
Although, ultrasonication could be an alternative method
to the thermal pasteurization of human milk, it would be
necessary to ensure that the temperature of the human milk
during ultrasonication remains below the level that causes a
precipitous fall in the activity of BSSL (a marker enzyme
for temperature denaturation of bioactive proteins). However
a longer exposure time to ultrasound would be required to
enhance possible synergistic treatment effects between
temperature and ultrasound.
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